IRIS
BELCARO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.426
EU - Europa 4.809
AS - Asia 3.260
SA - Sud America 188
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 11
Totale 13.732
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.366
SG - Singapore 1.222
CN - Cina 1.035
UA - Ucraina 923
IE - Irlanda 901
TR - Turchia 648
IT - Italia 631
SE - Svezia 570
GB - Regno Unito 441
FR - Francia 365
DE - Germania 359
FI - Finlandia 191
BR - Brasile 161
IN - India 152
RU - Federazione Russa 151
PL - Polonia 79
HK - Hong Kong 53
BE - Belgio 35
CA - Canada 33
ES - Italia 30
KR - Corea 28
NL - Olanda 24
AT - Austria 22
CZ - Repubblica Ceca 22
TH - Thailandia 22
IR - Iran 19
AU - Australia 17
JP - Giappone 16
AR - Argentina 15
MX - Messico 15
VN - Vietnam 15
EU - Europa 13
PT - Portogallo 12
TW - Taiwan 12
CH - Svizzera 11
GR - Grecia 10
ID - Indonesia 10
NZ - Nuova Zelanda 7
BD - Bangladesh 6
RO - Romania 6
DK - Danimarca 5
PK - Pakistan 5
EC - Ecuador 4
HR - Croazia 4
IL - Israele 4
NI - Nicaragua 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
ZA - Sudafrica 3
CO - Colombia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
IQ - Iraq 2
KE - Kenya 2
LT - Lituania 2
LU - Lussemburgo 2
MA - Marocco 2
MY - Malesia 2
PY - Paraguay 2
SI - Slovenia 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
EG - Egitto 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MC - Monaco 1
ME - Montenegro 1
MK - Macedonia 1
PA - Panama 1
PE - Perù 1
SA - Arabia Saudita 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.732
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.180
Chandler 906
Dublin 894
Singapore 826
Princeton 438
Izmir 363
Nanjing 349
Southend 346
Wilmington 189
Cambridge 188
Altamura 183
Santa Clara 156
Ashburn 137
Ann Arbor 129
Nanchang 120
Dearborn 110
Beijing 103
The Dalles 100
Boardman 71
Kraków 65
Shenyang 63
Hebei 56
Kunming 48
Tianjin 48
Woodbridge 44
Hong Kong 43
Jiaxing 41
New York 37
Los Angeles 36
Changsha 31
Munich 30
Norwalk 30
Brussels 29
Washington 23
Chieti 22
Falls Church 21
Hangzhou 21
Guangzhou 19
Moscow 18
Rome 17
Seattle 17
Brno 16
Grevenbroich 16
Lanzhou 16
Milan 16
Houston 15
London 15
San Mateo 15
Helsinki 14
Jinan 14
Vienna 14
Foggia 13
Shanghai 13
Changchun 12
Ningbo 12
Hanover 11
Auburn Hills 10
Augusta 10
Istanbul 10
São Paulo 10
Toronto 10
Warsaw 9
Amsterdam 8
Bangkok 8
Collecorvino 8
Guardiagrele 8
Hanoi 8
Nuremberg 8
Orange 8
Tokyo 8
Ankara 7
Chennai 7
Kuopio 7
Redwood City 7
Zhengzhou 7
Bengaluru 6
Dong Ket 6
Frankfurt am Main 6
Hillsboro 6
Leawood 6
Madrid 6
Mcallen 6
Mountain View 6
Naples 6
Tehran 6
Atlanta 5
Chiang Mai 5
Dallas 5
Garbagnate Milanese 5
Hefei 5
Seoul 5
Taichung 5
Taipei 5
Telde 5
Yeongdeungpo-gu 5
Ada 4
Adelaide 4
Athens 4
Auckland 4
Bari 4
Totale 8.047
Salva come PNG Salva come JPEG
Nome #
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 309
Beanblock® (standardized dry extract of Phaseolus vulgaris) in mildly overweight subjects: a pilot study. 131
Centella asiatica (Centellicum®) facilitates the regular healing of surgical scars in subjects at high risk of keloids. 128
Venoruton vs Daflon: evaluation of effects on qualità of life chronic venous insuffciency 128
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 125
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 120
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 119
Postoperative pulmonary infections: role of antibiotic treatment 117
Robuvit® and endurance in triathlon: improvements in training performance, recovery and oxidative stress 116
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 114
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 107
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 105
Mononucleosis-related fatigue: supplementary management with Robuvit®. 104
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 102
Incidence of perioperative stroke during peripheral revascularization or aortocoronary bypass in patients with carotid bruit and stenosis 99
Jet-lag: prevention with Pycnogenol. Preliminary report: evaluation in healthy individuals and in hypertensive patients 99
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 99
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 98
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 96
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 96
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 95
Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins 94
The value of segmental pressure measurement in the assessment of peripheral vascular disease. 93
Topical heparin: New observations 93
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 92
Treatment of Osteoarthritis with Pycnogenol®. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of Signs, Symptoms,Physical Performance and Vascular Aspects 91
Treatment of ankle sprain in patients with vascular diseases of the lower limbs 90
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 90
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 90
Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit® 90
Circulating endothelail cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venoruton 89
Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol. 89
Robuvit®: improvement of fatigue in medical convalescence. 88
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 87
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 87
Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study 84
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 83
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 83
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 83
Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol. 82
[Comparison of netilmicin with other aminoglycosides in severe surgical infections]. 82
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 82
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed® Versus Placebo 82
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 81
Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document. 81
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 81
Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment. 81
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 81
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 81
Clinical evaluation of defibrotide in the treatment of arterial and venous vascular disease. A preliminary report. 80
[Breast cancer. Epidemiology and other factors related to incidence in various populations]. 80
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 80
Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. 79
Venous ulcers: microcirculatory improvement and faster healing with local use of Pycnogenol 79
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 78
Cramps and Muscular Pain: Prevention with Pycnogenol((R)) in Normal Subjects, Venous Patients, Athletes, Claudicants and in Diabetic Microangiopathy 78
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. 78
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 77
Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®). 77
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 76
O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study 76
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 76
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 76
Pycnogenol may alleviate adverse effects in oncologic treatment 75
Management of uncomplicated ankle sprains with topical or oral ketoprofen treatment. A registry study 75
Superficial vein thrombosis (SVT), diffusion of thrombotic diseases, and increased global thrombogenicity: SVT as an important spy disease indicating environmental contamination by estrogens - Introduction 75
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 75
5-Year Control and Treatment of Edema and Increased Capillary Filtration in Venous Hypertension and Diabetic Microangiopathy Using O-(β-Hydroxyethyl)-Rutosides: A Prospective Comparative Clinical Registry 74
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 74
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 74
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 73
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 73
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 73
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. 72
Methods of Evaluation and Quantification of Microangiopathy in High Perfusion Microangiopathy (Chronic Venous Insufficiency and Diabetic Microangiopathy) 72
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 72
Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial. 71
Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study. 71
THE VENOUS CLINIC 71
Local heparin, superficial vein thrombosis 71
Microcirculatory effects of Viatromb® spray gel heparin in chronic venous insufficiency: Evaluation of TcPO2 and PCO2 - A product evaluation study 71
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 71
Capillary filtration in venous hypertension: evaluation with the vacuum suction chamber device and strain-gauge plethysmography. 70
Improvement of common cold with Pycnogenol®: a Winter registry study. 70
A controlled study shows daily intake of 50 mg of French Pine Bark Extract (Pycnogenol®) lowers plasma reactive oxygen metabolites in healthy smokers. 70
Effects of shock waves on microcirculation, perfusion, and pain management in critical limb ischemia. 69
Improvement in cochlear flow in patients with tinnitus with the complex supplement Acustop: a product evaluation 69
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 69
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 69
Trombosi venose ed embolie 69
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 69
Supplementation with Robuvit® in post-mastectomy post-radiation arm lymphedema. 69
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 69
Assessment of the activity of an oral contraceptive on the levels of oxidative stress and changes in oxidative stress after co-treatment with two different types of physiological modulators with antioxidant action. 68
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. 68
PycnoRacer®, a fitness drink including Pycnogenol®, improves recovery and training in the Cooper test 68
Laser doppler flux in the venous wall 67
null 67
LINFAVENIX: improvement of signs and symptoms of chronic venous insufficiency and microangiopathy 67
Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study 67
Totale 8.624
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020309 0 0 0 0 0 0 0 0 0 0 273 36
2020/20211.109 217 21 233 30 87 262 20 9 84 92 19 35
2021/2022870 16 18 15 166 77 25 19 65 68 17 101 283
2022/20232.726 272 407 157 284 234 572 181 177 276 26 88 52
2023/20241.149 88 50 65 26 49 288 335 38 24 50 33 103
2024/20252.633 266 689 531 55 78 94 64 149 394 148 165 0
Totale 14.212